Integer Holdings Co. (NASDAQ:ITGR)’s share price hit a new 52-week low during trading on Monday . The company traded as low as $21.81 and last traded at $22.42, with a volume of 128,894 shares trading hands. The stock had previously closed at $22.19.

A number of equities analysts recently commented on ITGR shares. TheStreet downgraded Integer Holdings from a “hold” rating to a “sell” rating in a report on Friday, July 1st. Zacks Investment Research raised Integer Holdings from a “sell” rating to a “hold” rating in a research note on Thursday, May 19th. Finally, Sterne Agee CRT reaffirmed a “buy” rating on shares of Integer Holdings in a research note on Monday, May 16th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $57.00.

The stock has a 50 day moving average of $0.00 and a 200-day moving average of $0.00. The firm’s market capitalization is $688.71 million.

Integer Holdings (NASDAQ:ITGR) last announced its earnings results on Thursday, July 28th. The company reported $0.56 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.70 by $0.14. The company earned $348.38 million during the quarter, compared to analysts’ expectations of $356.72 million. During the same quarter last year, the business posted $0.73 EPS. Integer Holdings’s revenue was up 99.2% compared to the same quarter last year. On average, equities analysts forecast that Integer Holdings Co. will post $2.64 EPS for the current fiscal year.

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.